Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 2
2001 1
2003 1
2004 1
2005 1
2006 4
2008 1
2009 2
2010 2
2011 6
2012 5
2013 3
2014 4
2015 8
2016 5
2017 5
2018 3
2019 5
2020 9
2021 11
2022 11
2023 9
2024 8
2025 11
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?
Raiser P, Schleiermacher G, Gambart M, Dumont B, Defachelles AS, Thebaud E, Tandonnet J, Pasqualini C, Proust S, Entz-Werle N, Aerts I, Ndounga-Diakou LA, Petit A, Puiseux C, Khanfar C, Rouger J, Mansuy L, Benadiba J, Millot F, Pluchart C, Laghouati S, Geoerger B, Vassal G, Valteau-Couanet D, Berlanga P. Raiser P, et al. Among authors: defachelles as. Eur J Cancer. 2024 May;202:114001. doi: 10.1016/j.ejca.2024.114001. Epub 2024 Mar 11. Eur J Cancer. 2024. PMID: 38489858 Free article.
Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial.
Defachelles AS, Bogart E, Casanova M, Merks JHM, Bisogno G, Calareso G, Gallego Melcon S, Gatz SA, Le Deley MC, McHugh K, Probst A, Rocourt N, van Rijn RR, Wheatley K, Minard-Colin V, Chisholm JC. Defachelles AS, et al. J Clin Oncol. 2021 Sep 20;39(27):2979-2990. doi: 10.1200/JCO.21.00124. Epub 2021 Aug 3. J Clin Oncol. 2021. PMID: 34343032 Clinical Trial.
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial.
Bisogno G, Chisholm J, Hladun R, De Salvo GL, Guerin F, Casanova M, Mandeville H, Alaggio R, Coppadoro B, Orbach D, Ferrari A, van Rijn R, Defachelles AS, Ben-Arush M, Glosli H, Cesen M, Merks JHM, Minard-Colin V. Bisogno G, et al. Among authors: defachelles as. J Clin Oncol. 2025 Jun;43(16):1856-1862. doi: 10.1200/JCO-24-02850. Epub 2025 Mar 7. J Clin Oncol. 2025. PMID: 40053891 Clinical Trial.
Relapsed rhabdomyosarcoma: treatment recommendations from the European pediatric soft tissue sarcoma study group (EpSSG).
Defachelles AS, Breunis WB, Casanova M, Minard-Collin V, Hjadun R, Wasti A, Dávila Fajardo R, Terwisscha van Scheltinga S, Heenen D, Heinz AT, Sparber-Sauer M, Merks JHM, Chisholm JC, Gatz SA. Defachelles AS, et al. Br J Cancer. 2025 Dec;133(11):1591-1598. doi: 10.1038/s41416-025-03130-1. Epub 2025 Sep 5. Br J Cancer. 2025. PMID: 40913059 Review.
Therapy and Outcomes of Patients with Relapsed Nonmetastatic Rhabdomyosarcoma: A Report from the French Society of Pediatric Oncology Malignant Mesenchymal Tumor Committee.
Sevrin F, Bogart E, Orbach D, Le Deley MC, Berlanga P, Bernier V, Corradini N, Fayard C, Guerin F, Jannier S, Karanian M, Proust S, Rome A, Verité C, Minard-Colin V, Defachelles AS. Sevrin F, et al. Among authors: defachelles as. Cancer Med. 2024 Dec;13(23):e70420. doi: 10.1002/cam4.70420. Cancer Med. 2024. PMID: 39610307 Free PMC article.
Reply to H. B et al.
Defachelles AS, Bogart E, Casanova M, Merks JHM, Bisogno G, Calareso G, Melcon SG, Gatz SA, Le Deley MC, McHugh K, Probst A, Rocourt N, van Rijn RR, Minard-Colin V, Chisholm JC. Defachelles AS, et al. J Clin Oncol. 2022 Mar 20;40(9):1030-1032. doi: 10.1200/JCO.21.02612. Epub 2022 Feb 7. J Clin Oncol. 2022. PMID: 35130027 No abstract available.
Childhood, Adolescent and Young Adult Poor-Prognosis Rhabdomyosarcoma.
Wasti AT, Bisogno G, Hladun R, Defachelles AS, Casanova M, Breunis WB, Gatz SA, Schoot RA, Ferrari A, Jenney M, Alaggio R, Davila Fajardo R, Terwisscha van Scheltinga S, Shipley J, Meister MT, R van Rijn R, Anderson J, Sparber-Sauer M, Chisholm JC, Merks JHM. Wasti AT, et al. Among authors: defachelles as. Cancers (Basel). 2025 Sep 23;17(19):3100. doi: 10.3390/cancers17193100. Cancers (Basel). 2025. PMID: 41097629 Free PMC article. Review.
Neuroblastoma in Infants: Long-Term Survival From INES Protocols A SIOPEN Study.
Savagner J, Munzer C, Schleiermacher G, Garaventa A, Haupt R, Sorrentino S, Mazzocco K, Di Cataldo A, Canete A, Segura V, Ramal D, Wheeler K, Ladenstein R, de Lacerda AF, Brichard B, Beck-Popovic M, Valteau-Couanet D, Pasqualini C, Coze C, Dumont B, Defachelles AS, Gambart M. Savagner J, et al. Among authors: defachelles as. Pediatr Blood Cancer. 2025 Nov;72(11):e31982. doi: 10.1002/pbc.31982. Epub 2025 Aug 18. Pediatr Blood Cancer. 2025. PMID: 40827024
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial.
Gatz SA, Harttrampf AC, Brard C, Bautista F, André N, Abbou S, Rubino J, Rondof W, Deloger M, Rübsam M, Marshall LV, Hübschmann D, Nebchi S, Aerts I, Thebaud E, De Carli E, Defachelles AS, Paoletti X, Godin R, Miah K, Mortimer PGS, Vassal G, Geoerger B. Gatz SA, et al. Among authors: defachelles as. Clin Cancer Res. 2024 Feb 16;30(4):741-753. doi: 10.1158/1078-0432.CCR-23-2959. Clin Cancer Res. 2024. PMID: 38051741 Clinical Trial.
103 results